Sepsis Alliance, USA
Paul L. Epner, MBA, MEd is a strategic problem-solver focused on improving patient outcomes especially through a focus on the process of diagnosis and on the clinical laboratory. After a 31-year career at Abbott Diagnostics across three countries that included the creation and directing of Abbott’s Labs are Vital program, he co-founded the nonprofit Society to Improve Diagnosis in Medicine (SIDM) and led the organization as CEO until stepping down in late 2021 after ten years. During his tenure, he created and chaired the Coalition to Improve Diagnosis, served as a member of the National Steering Committee for Patient Safety, and was a member of the National Quality Forum’s 2021 Leadership Consortium. Following his retirement from SIDM in 2021, he joined the Board of Directors of Sepsis Alliance and most recently was elected to be Vice-Chair of the Board. Additionally, he is a co-investigator on a four-year AHRQ-funded research effort to study the root causes of delayed cancer diagnosis and to develop strategies for mitigating them. Previously, he served on the Board of the Clinical Laboratory Management Association (CLMA) serving as President for 2 years and on multiple programs at the Centers for Disease Control and Prevention.
Paul Epner reported the following relevant financial disclosures:
• Consultant Fee: Abbott
Senior Policy Director
Institution of Health Economics, Canada
John Sproule is the Institute of Health Economics’ Senior Policy Director. His main background has been working in the public sector in Canada, working in senior positions in government, government agencies and health authorities involved in managing health systems. He also has worked for the private health industry sector both in Canada and Australia. He currently sits on the Advisory Committee for the North American Observatory on Health Systems and Policies and has been a Board member with the Canadian Health Economics Research Association, the Canadian Association for Population Therapeutics, the Canadian Association for Health Services and Policy Research, Health Technology Assessment International, and Chair of the US/Canada Pacific Northwest Economic Region Health Care Working Group. In 2022 John received the Queen Elizabeth II Platinum Jubilee Medal for his contributions to ongoing innovation in the Canadian and Alberta health system.
John Sproule reported no relevant financial disclosures.
Chief Scientific Officer
TriCore Reference Laboratories, USA
Dr. Grenache is the chief scientific officer for TriCore Reference Laboratories in Albuquerque, New Mexico. In that role, he leads the TriCore Research Institute and works cooperatively to develop and implement TriCore’s scientific research strategy.
He is also the laboratory director of TriCore’s flagship Core Laboratory, the medical director of immunology and of point-of-care testing, and a clinical professor of pathology at the University of New Mexico.
Dr. Grenache earned his PhD in biomedical sciences from WPI in Worcester, Massachusetts, and completed postdoctoral training in clinical chemistry at Washington University School of Medicine in St. Louis, Missouri. He is a diplomate of the American Board of Clinical Chemistry, a Fellow in the AACC Academy, and an AACC past-president. His research interests are centered on leveraging longitudinal laboratory data to gain insights into population health.
David Grenache reported no relevant financial disclosures.